Peer-influenced content. Sources you trust. No registration required. This is HCN.
JAMA Network
In 2019, the FDA warned that gabapentin might cause serious breathing difficulties when used with drugs that depress the central nervous system. The warning may have not been heeded, as overdose deaths in which gabapentin was detected doubled from 449 in the first quarter of 2019 to 959 in the second quarter of 2020.
Neurology July 12th 2022
Medical Professionals Reference (MPR)
As use of gabapentin in the United States has been steadily increasing in recent years, researchers from the CDC have found that, among the 62,652 overdose deaths that occurred between 2019 and 2020, 58,362 of these cases had documented toxicology results.
Clinical Pharmacology May 24th 2022